Home LiteratureArticle Details
PMID: 15717863 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.

The Biochemical journal ·Vol. 388 ·No. Pt 3 ·2005-06-15 ·Pages 857-67

Wang XJ, Chamberlain M, Vassieva O, Henderson CJ, Wolf CR

Abstract

Cytochrome P450 reductase is the unique electron donor for microsomal cytochrome P450s; these enzymes play a major role in the metabolism of endogenous and xenobiotic compounds. In mice with a liver-specific deletion of cytochrome P450 reductase, hepatic cytochrome P450 activity is ablated, with consequent changes in bile acid and lipid homoeostasis. In order to gain insights into the metabolic changes resulting from this phenotype, we have analysed changes in hepatic mRNA expression using microarray analysis and real-time PCR. In parallel with the perturbations in bile acid levels, changes in the expression of key enzymes involved in cholesterol and lipid homoeostasis were observed in hepatic cytochrome P450 reductase null mice. This was characterized by a reduced expression of Cyp7b1, and elevation of Cyp7a1 and Cyp8b1 expression. The levels of mRNAs for other cytochrome P450 genes, including Cyp2b10, Cyp2c29, Cyp3a11 and Cyp3a16, were increased, demonstrating that endogenous factors play a role in regulating the expression of these proteins and that the increases are due, at least in part, to altered levels of transcripts. In addition, levels of mRNAs encoding genes involved in glycolysis and lipid transport were also increased; the latter may provide an explanation for the increased hepatic lipid content observed in the hepatic null mice. Serum testosterone and oestradiol levels were lowered, accompanied by significantly decreased expression of Hsd3b2 (3beta-hydroxy-Delta5-steroid dehydrogenase-2), Hsd3b5 (3beta-hydroxy-Delta5-steroid dehydrogenase-5) and Hsd11b1 (11beta-hydroxysteroid dehydrogenase type 1), key enzymes in steroid hormone metabolism. These microarray data provide important insights into the control of metabolic pathways by the cytochrome system.

MeSH Terms
Animals Carbohydrate Metabolism Cholesterol/metabolism Cytoskeleton/metabolism Gene Deletion Gene Expression Profiling Gene Expression Regulation Glycolysis/genetics Hormones/metabolism Immunity/genetics Lipid Metabolism Liver/metabolism Mice Mice, Knockout NADPH-Ferrihemoprotein Reductase/deficiency,genetics,metabolism Neoplasms/genetics Oligonucleotide Array Sequence Analysis Oxidative Stress/genetics Phenotype Phosphorylation RNA, Messenger/analysis,metabolism Signal Transduction/genetics
Chemicals
Hormones RNA, Messenger Cholesterol NADPH-Ferrihemoprotein Reductase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wang Xiu Jun
Biomedical Research Centre, Level 5, Ninewells Hospital & Medical School, Dundee DD1 9SY, UK.
Chamberlain Mark
Vassieva Olga
Henderson Colin J
Wolf C Roland
References (50)
50 references, click to expand
  1. Pharmacogenetics of cytochromes P450.
    Mol Aspects Med. 1999 Feb-Apr;20(1-2):12-24, 25-137 PMID: 10575648
  2. Regulation of stearoyl-CoA desaturases and role in metabolism.
    Prog Lipid Res. 2004 Mar;43(2):91-104 PMID: 14654089
  3. Leptin-specific patterns of gene expression in white adipose tissue.
    Genes Dev. 2000 Apr 15;14(8):963-80 PMID: 10783168
  4. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.
    Mol Cell. 2000 Sep;6(3):507-15 PMID: 11030331
  5. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.
    Mol Cell. 2000 Sep;6(3):517-26 PMID: 11030332
  6. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
    Cell. 2000 Sep 15;102(6):731-44 PMID: 11030617
  7. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis.
    Annu Rev Cell Dev Biol. 2000;16:459-81 PMID: 11031244
  8. Differential contributions of NADPH-cytochrome P450 oxidoreductase FAD binding site residues to flavin binding and catalysis.
    J Biol Chem. 2000 Dec 29;275(52):41087-91 PMID: 11022049
  9. Lipoprotein lipase: physiology, biochemistry, and molecular biology.
    Front Biosci. 2001 Mar 1;6:D388-405 PMID: 11229871
  10. Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner.
    J Biol Chem. 2001 Nov 23;276(47):43915-23 PMID: 11522786
  11. Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors.
    Biochim Biophys Acta. 2003 Feb 17;1619(3):223-34 PMID: 12573481
  12. Induction of drug metabolism: the role of nuclear receptors.
    Pharmacol Rev. 2003 Dec;55(4):649-73 PMID: 14657421
  13. Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation.
    J Biol Chem. 2004 Jan 23;279(4):2480-9 PMID: 14583614
  14. Interaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells.
    Diabetes. 2004 Apr;53(4):1020-9 PMID: 15047617
  15. CAR, driving into the future.
    Mol Endocrinol. 2004 Jul;18(7):1589-98 PMID: 14988430
  16. Solubilization and partial characterization of rat liver squalene epoxidase.
    J Biol Chem. 1975 Feb 25;250(4):1571-9 PMID: 234459
  17. Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase.
    J Biol Chem. 1979 Sep 25;254(18):8976-81 PMID: 113406
  18. Evidence for a new physiological role of hepatic NADPH:ferricytochrome (P-450) oxidoreductase. Direct electron input to the microsomal fatty acid chain elongation system.
    J Biol Chem. 1981 Oct 10;256(19):10066-72 PMID: 6792195
  19. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis.
    J Biol Chem. 1989 May 5;264(13):7584-9 PMID: 2708380
  20. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
    Cell. 1995 Dec 1;83(5):803-12 PMID: 8521497
  21. Fatty acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes.
    Eur J Biochem. 1995 Dec 1;234(2):390-6 PMID: 8536680
  22. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation.
    J Biol Chem. 1996 Jul 26;271(30):18017-23 PMID: 8663429
  23. Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase.
    J Biol Chem. 1996 Jul 26;271(30):18024-31 PMID: 8663430
  24. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.
    J Lipid Res. 1996 Apr;37(4):693-707 PMID: 8732771
  25. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
    EMBO J. 1996 Oct 1;15(19):5336-48 PMID: 8895578
  26. The heme oxygenase system: a regulator of second messenger gases.
    Annu Rev Pharmacol Toxicol. 1997;37:517-54 PMID: 9131263
  27. Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene.
    Mol Pharmacol. 1998 Apr;53(4):597-601 PMID: 9547348
  28. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.
    Cell. 1998 May 29;93(5):693-704 PMID: 9630215
  29. A novel relative of the very-long-chain acyl-CoA synthetase and fatty acid transporter protein genes with a distinct expression pattern.
    Biochem Biophys Res Commun. 1998 Jun 18;247(2):255-60 PMID: 9642112
  30. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver.
    J Biol Chem. 1998 Dec 25;273(52):35299-306 PMID: 9857071
  31. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.
    Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):266-71 PMID: 9874807
  32. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis.
    Curr Opin Lipidol. 1999 Apr;10(2):143-50 PMID: 10327282
  33. Identification of a nuclear receptor for bile acids.
    Science. 1999 May 21;284(5418):1362-5 PMID: 10334992
  34. Bile acids: natural ligands for an orphan nuclear receptor.
    Science. 1999 May 21;284(5418):1365-8 PMID: 10334993
  35. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.
    Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11041-8 PMID: 10500120
  36. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver.
    J Biol Chem. 2001 Dec 28;276(52):49066-76 PMID: 11551957
  37. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital.
    Mol Pharmacol. 2002 Jan;61(1):1-6 PMID: 11752199
  38. Evidence for selective induction of phosphoenolpyruvate carboxykinase gene expression by unsaturated and nonmetabolized fatty acids in adipocytes.
    J Cell Biochem. 2002;85(3):651-61 PMID: 11968005
  39. Expression and localization of aquaporin water channels in rat hepatocytes. Evidence for a role in canalicular bile secretion.
    J Biol Chem. 2002 Jun 21;277(25):22710-7 PMID: 11932260
  40. Bile acid regulation of gene expression: roles of nuclear hormone receptors.
    Endocr Rev. 2002 Aug;23(4):443-63 PMID: 12202460
  41. Heme degradation and human disease: diversity is the soul of life.
    Antioxid Redox Signal. 2002 Aug;4(4):593-602 PMID: 12230871
  42. Clinical importance of the cytochromes P450.
    Lancet. 2002 Oct 12;360(9340):1155-62 PMID: 12387968
  43. Functional and structural comparison of PXR and CAR.
    Biochim Biophys Acta. 2003 Feb 17;1619(3):235-8 PMID: 12573482
  44. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors.
    Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G349-56 PMID: 12576301
  45. Apo A-IV: an update on regulation and physiologic functions.
    Biochim Biophys Acta. 2003 Mar 17;1631(2):177-87 PMID: 12633684
  46. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
    J Biol Chem. 2003 Apr 11;278(15):13480-6 PMID: 12566435
  47. Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse.
    EHP Toxicogenomics. 2003 Jan;111(1T):45-51 PMID: 12735109
  48. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
    J Biol Chem. 2003 Jul 11;278(28):25895-901 PMID: 12697746
  49. The enzymes, regulation, and genetics of bile acid synthesis.
    Annu Rev Biochem. 2003;72:137-74 PMID: 12543708
  50. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.
    Arch Biochem Biophys. 2000 Feb 15;374(2):293-8 PMID: 10666310
Article Info
Journal
The Biochemical journal
Abbr.
Biochem J
ISSN
1470-8728
Published
2005-06-15
Pages
857-67
Language
English
Region
England
NLM ID
2984726R
PMCID
PMC1183466
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]